ArticleDiabetes care2013

Comment on: Rizzo et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-2082.

Antoine Makdissi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.